Serum biomarkers as early indicators of outcomes in spontaneous subarachnoid hemorrhage
Early biomarker assessment enhances sSAH prognosis, complementing neuroimaging. GFAP and S100 strongly correlate with brain injury severity, while sST2 predicts 3-months outcomes. Integrating these biomarkers into routine practice may improve early risk stratification and patient management.
Authors
- Grazia Menna (ORCID: https://orcid.org/0000-0003-2594-4967)
- Renata Martinelli
- Alessandro Olivi (ORCID: https://orcid.org/0000-0002-4489-7564)
- Annamaria Auricchio (ORCID: https://orcid.org/0000-0002-4186-4476)
- Giovanni Maria Ceccarelli
- Silvia Baroni (ORCID: https://orcid.org/0009-0009-8528-7533)
- Giuseppe Maria Della Pepa (ORCID: https://orcid.org/0000-0001-8698-3359)
- Andrea Urbani (ORCID: https://orcid.org/0000-0002-8905-0922)
- Giulia Napoli (ORCID: https://orcid.org/0009-0006-0279-730X)
- Luca Scarcia
- Marco Obersnel
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Hôpitaux Universitaires Henri-Mondor (FR)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1515/cclm-2025-0309
- Citations
- 1
- Primary Topic
- Intracranial Aneurysms: Treatment and Complications
- Type
- article
- Field-Weighted Citation Impact
- 1.39